Chronic Kidney Disease

ATLANTA — A remote, team-based approach with immediate initiation of necessary medications improved guideline-directed medical therapy use at 6 months for patients with diabetes at high CV or renal risk, researchers reported.

Editor’s note: Healio interviewed Brendan T. Bowman, MD, program chair of the Renal Physicians Association Annual Meeting, taking place April 11-14 in Baltimore.

Higher ambient heat exposure may be associated with accelerated eGFR decline in patients with chronic kidney disease, according to a post-hoc analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease trial.

Using an electronic health record algorithm and practice facilitators in primary care did not reduce hospitalizations in adults with chronic kidney disease, type 2 diabetes and hypertension, according to results of a study.

Nephrology practices could leave the Kidney Care Choices model for patients with chronic kidney disease because of planned reductions in Medicare payments that are “much larger than anticipated,” according to a nephrology advocacy group.

An expert panel released the first consensus statement on performance measures to identify remission and evaluate the effectiveness of lifestyle treatment medications.

Patients with chronic kidney disease and normoalbuminuria had higher risk for disease progression that increased in a linearly relationship with higher albuminuria levels, according to data.

A kidney failure risk equation model had acceptable discrimination and calibration, and “better clinical utility” than an eGFR-based strategy to assess kidney failure rates in Chinese patients, according to a study in Kidney Medicine.

Patients with chronic kidney disease have limited opportunities to engage in shared-decision-making with their physicians, according to a published Danish study.

Nephrologists at West Virgina University Medicine have entered into an agreement to join the Interwell Health physician network.